(Q35531488)

8 August 2017

1 reference

title

Integrated services for treatment of schizophrenic substance abusers: demographics, symptoms, and substance abuse patterns (English)

1 reference

8 August 2017

0 references

0 references

1 reference

R. N. Rosenthal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1438603

26 September 2022

D. J. Hellerstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1438603

26 September 2022

C. R. Miner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1438603

26 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1438603

26 September 2022

publication date

1 January 1992

1 reference

8 August 2017

published in

Psychiatric Quarterly

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

3-26

1 reference

Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Substance use in young adults with schizophrenic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

The prevalence of psychiatric disorders in patients with alcohol and other drug problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Impact of substance abuse on the course and outcome of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Discharged state hospital patients' characteristics and use of aftercare: effect on community tenure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Research diagnostic criteria: rationale and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Negative symptoms in schizophrenia. Definition and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Negative v positive schizophrenia. Definition and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Dopaminergic mechanisms in idiopathic and drug-induced psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Postpsychotic Depressive Symptoms in Hospitalized Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Marijuana use in schizophrenia: a clear hazard

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01064679

Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function

21 January 2018

1 reference

12 December 2020

Recent psychostimulant use in hospitalized schizophrenics

1 reference

12 December 2020

Alcohol use and abuse in schizophrenia. A prospective community study

1 reference

12 December 2020

Clinical correlates of readmission in a schizophrenic cohort

1 reference

12 December 2020

Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity

1 reference

12 December 2020

Psychiatric disorders in opioid-dependent patients.

1 reference

12 December 2020

Treatment patterns of young chronic schizophrenic patients in the era of deinstitutionalization.

1 reference

12 December 2020

The problem with interpreters: communicating with Spanish-speaking patients.

1 reference

12 December 2020

Substance abuse among general psychiatric patients: place of presentation, diagnosis, and treatment

1 reference

12 December 2020

Psychopathology in substance abusers: diagnosis and treatment

1 reference

12 December 2020

Psychosocial treatment of negative symptoms in schizophrenia

1 reference

12 December 2020

Correlates of acting-out behaviors among young adult chronic patients.

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Diagnosis of alcohol use disorders in schizophrenia

1 reference

12 December 2020

New data from the Addiction Severity Index. Reliability and validity in three centers

1 reference

12 December 2020

Characteristics of young adults with schizophrenic disorders treated in the community.

1 reference

12 December 2020

1 reference

12 December 2020

Treatment response in psychiatrically impaired drug abusers.

1 reference

12 December 2020

An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

1 reference

12 December 2020

Substance abuse in the elderly: over-the-counter and illegal drugs

1 reference

12 December 2020

Drug abuse in schizophrenia

1 reference

12 December 2020

Treatment Cost and Rehospitalization Rate in Schizophrenic Outpatients With a History of Substance Abuse

1 reference

12 December 2020

Development of psychiatric illness in drug abusers. Possible role of drug preference

1 reference

12 December 2020

Positive and negative symptoms: historical and conceptual aspects

1 reference

12 December 2020

Frequency and patterns of drug abuse in psychiatric patients

1 reference

12 December 2020

Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey

1 reference

12 December 2020

The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence

1 reference

12 December 2020

Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history

1 reference

12 December 2020

Inner-city substance abuse patterns: a study of psychiatric inpatients

1 reference

12 December 2020

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

12 December 2020

Cannabis and neuroleptic agents in schizophrenia

1 reference

12 December 2020

A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01064679

1 reference

8 August 2017

1 reference